Gambling prevalence and practices in France in 2010
Tendances n° 77, OFDT, 8 p.
In France, there have been several recent public reports (Trucy, 2006; INSERM, 2008) on gambling. The purpose of these reports was not only to examine the economic impact of gambling, but also the public health impact, given the personal and social problems that may result from problem gambling.
However, the scope of these problems was not quantified. In order to fill this informational gap, the public authorities commissioned the OFDT to carry out the first national gambling prevalence survey in France. This survey was conducted as part of the INPES (the French National Institute for Prevention and Health Education) Baromètre santé 2010 health survey. The objective was to gather data on the number of gamblers, both occasional and regular, and to estimate the size of the problem gambling or pathological gambling population. Since this estimate only pertained to the period preceding the opening up of the French online gambling market to competition (French law of 12 May 2010), it cannot be used to measure the impact of this legislation on the prevalence of problem or pathological gambling.
Jean-Michel Costes, Maud Pousset, Vincent Eroukmanoff, Olivier Le Nezet, Jean-Baptiste Richard, Romain Guignard, François Beck, Pierre Arwidson
Download the PDF file (425 Ko)
Drugs in Europe
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.